03.10.2017
- Pfizer is suing Johnson & Johnson (J&J) in the US over what it terms anti-competitive practices against its biosimilar Inflectra. The lawsuit is said to be the first of its kind...
25.05.2017
- The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
06.08.2015
- European regulatory authorities have approved the $15.2 billion takeover of injectable drug and infusion device maker Hospira by US drugmaker Pfizer, subject to certain conditions...
